Selectis Health (GBCS) Other financing activities (2014 - 2025)

Selectis Health has disclosed Other financing activities across 11 years of filings, most recently posting $1500.0 for Q4 2025.

• Other financing activities for Q4 2025 came in at $1500.0, up 130.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $9400.0 (down 72.47% YoY), and the FY2025 annual result was $9400.0, down 72.47% from the prior year.
• Other financing activities came in at $1500.0 for Q4 2025 at Selectis Health, down from $2000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $37489.0 in Q4 2022 to a low of -$29019.0 in Q4 2021.
• The 5-year median for Other financing activities is $4449.5 (2022), against an average of $5235.0.
• Across the five-year window, Other financing activities slumped 1913.69% in 2021 and soared 466.6% in 2022, its largest moves.
• Selectis Health's Other financing activities stood at -$29019.0 in 2021, then soared by 229.19% to $37489.0 in 2022, then slumped by 75.03% to $9362.0 in 2023, then slumped by 151.81% to -$4850.0 in 2024, then soared by 130.93% to $1500.0 in 2025.
• The last three Other financing activities figures came in at $1500.0 (Q4 2025), $2000.0 (Q3 2025), and $2500.0 (Q2 2025), per Business Quant data.